1. Prognostic value of Midkine expression in patients with solid tumors: a systematic review and meta-analysis
   Luo Zhang et al, 2018, Oncotarget CrossRef
2. The Mystery of Syndecan-1 in Tumor Development and Progression
   Ilona Kovalszky et al, 2022, The Extracellular Matrix and the Tumor Microenvironment CrossRef
3. Syndecan-1 in Cancer: Implications for Cell Signaling, Differentiation, and Prognostication
   Tünde Szatmári et al, 2015, Disease Markers CrossRef
4. Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal Tissues
   Simon Kind et al, 2019, Disease Markers CrossRef
5. Comparison of Syndecan-1 Immunohistochemical Expression in Lobular and Ductal Breast Carcinoma with Nodal Metastases
   Ivana Miše et al, 2018, Analytical Cellular Pathology CrossRef
6. Role of ATF3 as a prognostic biomarker and correlation of ATF3 expression with macrophage infiltration in hepatocellular carcinoma
   Lijuan Li et al, 2021, BMC Medical Genomics CrossRef
7. Midkine (MDK) in Hepatocellular Carcinoma: More than a Biomarker
   Christiana Christou et al, 2024, Cells CrossRef
8. Clinicopathological and prognostic significance of SDC1 overexpression in breast cancer
   Xiangrong Cui et al, 2017, Oncotarget CrossRef
9. E2F2/5/8 Serve as Potential Prognostic Biomarkers and Targets for Human Ovarian Cancer
   Quan Zhou et al, 2019, Frontiers in Oncology CrossRef
10. Understanding the molecular association between hyperkalemia and lung squamous cell carcinomas
    Xianping Meng et al, 2020, BMC Medical Genetics CrossRef
11. Quantitative comparison of immunohistochemical and PCR analysis of midkine expression in breast cancer types and serum midkine level
    Hülya ÇETİN SORKUN et al, 2016, TURKISH JOURNAL OF MEDICAL SCIENCES CrossRef
12. Differential Expression of E2F Transcription Factors and Their Functional and Prognostic Roles in Human Prostate Cancer
    Zhaodong Han et al, 2022, Frontiers in Cell and Developmental Biology CrossRef